Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Collin

Showing results (151-160 of 155) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 155 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2019
Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational StudyJean Donadieu, Islam Amine Larabi, Mathilde Tardieu, et al.
Blood|July 15, 2022
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemiaRicky Tirtakusuma, Katarzyna Szoltysek, Paul Milne, et al.
Blood Advances|February 12, 2026
Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patientsJean Donadieu, Dmitry Evseev, Francesco Pegoraro, et al.
Blood|January 29, 2026
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemiaDiyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham, et al.
Blood|November 2, 2021
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibitionPaul G Kemps, Jennifer Picarsic, Benjamin H Durham, et al.
Pageof 16

Showing results (151-160 of 155) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 155 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2019
Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational StudyJean Donadieu, Islam Amine Larabi, Mathilde Tardieu, et al.
Blood|July 15, 2022
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemiaRicky Tirtakusuma, Katarzyna Szoltysek, Paul Milne, et al.
Blood Advances|February 12, 2026
Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patientsJean Donadieu, Dmitry Evseev, Francesco Pegoraro, et al.
Blood|January 29, 2026
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemiaDiyanath Ranasinghe, Wei-Yu Lin, Sarah E Fordham, et al.
Blood|November 2, 2021
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibitionPaul G Kemps, Jennifer Picarsic, Benjamin H Durham, et al.
Pageof 16